On the other hand, however, the appearance of CEPB4 upregulation in ovarian cancer cells treated with paclitaxel seems to take a relatively long period of time, since CPEB4 upregulation was not observed as an acute responding mechanism, at least within 72 h observed in our study, to paclitaxel exposure. The gene discussed is CPEB4; the disease is ovarian cancer.